Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS · Delayed Price · Currency is USD
0.0010
0.00 (0.00%)
Oct 2, 2025, 8:00 PM EDT
Anthera Pharmaceuticals Market Cap
Anthera Pharmaceuticals has a market cap or net worth of $26.18 thousand as of October 6, 2025. Its market cap has decreased by -97.73% in one year.
Market Cap
26.18K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 1, 2010, Anthera Pharmaceuticals's market cap has decreased from 10.98M to 26.18K, a decrease of -99.76%. That is a compound annual growth rate of -32.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 26.18K | 100,588.46% |
| Dec 31, 2024 | 26.00 | -98.52% |
| Dec 29, 2023 | 1.75K | -33.00% |
| Dec 30, 2022 | 2.62K | -99.58% |
| Dec 31, 2020 | 628.30K | -29.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 326.79M |
| American Oncology Network | 281.53M |
| Silence Therapeutics | 236.17M |